Searching for keyword:"Ventricular Arrythmia"

23 results
Record publications over time
Ironsift results are limited for unregistered users. Register or log in to see all records.

US Clinical Trial NCT03258112 – NIH – Aug 20, 2017

Safety and Efficacy of Catheter Ablation of Idiopathic Ventricular Arrhythmias Arising From Cardiac Outflow Tracts

The right and left ventricular outflow tracts (RVOT/LVOT) are the most common sites of origin for idiopathic ventricular tachycardia (VT) and premature ventricular contractions (PVCs) in patients without structural heart disease.1 Frequent PVCs was...
Full record

US Clinical Trial NCT03502499 – NIH – Apr 4, 2018

Half-normal Saline vs Normal Saline for Irrigation of Open-irrigated Radiofrequency Catheters in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation

No preview available.
Full record

US Clinical Trial NCT03632057 – NIH – Jul 19, 2018

Shock Efficacy, a Randomized Study Comparing Fixed Tilt and Fixed Pulse Width in a General Implantable-Cardioverter Population

No preview available.
Full record

US Clinical Trial NCT03842592 – NIH – Jan 28, 2019

Quantification of Ventricular Arrhythmia After Myocarditis in Sportsman

No preview available.
Full record

US Clinical Trial NCT03608670 – NIH – Jun 12, 2018

Extravascular ICD Pilot Study

The study will recruit male and female adult subjects that meet all of the inclusion criteria and none of the exclusion criteria. All subjects will be indicated to receive an ICD. The EV ICD system will be implanted and the subjects will be followe...
Full record

US Clinical Trial NCT03972865 – NIH – May 31, 2019

Cardiovascular Consequences and Risk of Ventricular Rhythm Disorder in Intense and Extended Physical Exercise

Background and rationale: While regular and moderate physical activity is strongly recommended in reducing cardiovascular risk, the scientific community questions the potentially harmful effects of prolonged and intense physical activity. In the sh...
Full record

US Clinical Trial NCT03977116 – NIH – Jun 5, 2019

Clinical Outcomes and Long Term Effects of Sodium-glucose Co-transporter 2 Inhibitors in Diabetes Mellitus and Failing Heart Patients With Implantable Cardioverter Defibrillator Undergoing Trans-catheter Ablation for Ventricular Arrhythmias.

SLGT2 therapy is safety used in heart failure (HF) patients with depressed left ventricle ejection fraction (LVEF) and diabetes mellitus (DM). Indeed, in these patients SGLT2 therapy reduces hospital admission for heart failure and mortality rate. T...
Full record

US Clinical Trial NCT03204981 – NIH – Jun 28, 2017

Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias

Radiofrequency (RF) ablation is the most commonly employed method for the catheter treatment of cardiac arrhythmias. Myocardial scar serves as the most frequent substrate for the genesis of both atrial and ventricular arrhythmias. Such scar frequent...
Full record

US Clinical Trial NCT03821051 – NIH – Jan 27, 2019

China Structural Ventricular Arrhythmias Registry, a Multicenter,Observational and Prospective Study.

In China, the prevalence and risk factors of malignant ventricular arrhythmias remain unclear. In addition ,the mainstream treatment relies on implantable devices and medication.China Malignant Ventricular Arrhythmias Study is a nation-wide complex...
Full record

US Clinical Trial NCT03495297 – NIH – Mar 23, 2018

A Prospective Randomised CompArative Trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation With and Without DeFibrillation Testing

Implantable Cardioverter Defibrillator (ICD) implant improves survival in patients with a higher risk for sudden cardiac death. There are 2 types of ICD available; transvenous ICD (TV-ICD) and subcutaneous ICD (S-ICD). During ICD implant, defibrilla...
Full record

US Clinical Trial NCT03831516 – NIH – Jan 25, 2019

Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias

Until recently, the only non-invasive diagnostic modality to help identify the location of ventricular arrhythmias was the 12 lead ECG. The Medtronic CardioInsight wearable vest is a recently FDA approved diagnostic modality noninvasive, single beat...
Full record
Register to view full records and receive email notifications.

US Clinical Trial NCT03210883 – NIH – Jul 3, 2017

Global Electrical Heterogeneity and Clinical Outcomes

No preview available.
Full record

US Clinical Trial NCT03766919 – NIH – Oct 16, 2018

Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector

FRIENDS study is a pre-market approval (INVICTA leads - devices under investigation - are not CE marked), interventional, prospective, longitudinal, international (European), multicenter, single arm study. The devices under investigation, the INVIC...
Full record

US Clinical Trial NCT03458273 – NIH – Feb 24, 2018

Multi-center, Observational, Retrospective Comparison of the Feasibility, Safety, and Efficacy of Real Zero Fluoroscopy Versus Conventional Fluoroscopic Catheter Ablation With and Without 3D System Support: Propensity Matched Study

Catheter ablation is a well-established treatment to treat patients with a wide scope of heart arrhythmias. The study is an investigator-initiated, retrospective analysis of prospectively collected data. The study population consists of patients wi...
Full record

US Clinical Trial NCT03475888 – NIH – Mar 12, 2018

Incidence of Ventricular Arrhythmias in Patients With Chronic Total Occlusion Recanalization

Rationale: Successful chronic total occlusion (CTO) recanalization has been associated with improved long-term survival. Furthermore, CTO is an independent predictor for the occurrence of ventricular arrhythmias (VA) in patients with ischemic cardio...
Full record

US Clinical Trial NCT03041519 – NIH – Jan 29, 2017

Multi-center, Randomized, Controlled, Prospective Trial to Compare the Feasibility, Safety, and Efficacy of Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias.

Catheter ablation is a well-established treatment to treat patients with a wide range of heart rhythm disturbances. Fluoroscopy is a imaging modality routinely used for the ablation of arrhythmias.Due to the rising concern regarding the harmful effe...
Full record

US Clinical Trial NCT03880708 – NIH – Mar 17, 2019

China Inherited Ventricular Arrhythmias Registry, a Multicenter, Observational and Prospective Study

In China, the prevalence and risk factors of malignant ventricular arrhythmias remain unclear. In addition, mainstream treatment relies on implantable devices and medication. China Malignant Ventricular Arrhythmias Study is a nation-wide complex con...
Full record

US Clinical Trial NCT03022487 – NIH – Jan 9, 2017

Multicentre Investigation of Novel Electrocardiogram Risk Markers in Ventricular Arrhythmia Prediction (MINERVA)

No preview available.
Full record

US Clinical Trial NCT03188341 – NIH – Jun 8, 2017

The Reasons of Repolarization Disturbances Disclosure in Vascular Surgery

Vascular surgery is thought as the highest risk procedure in the context of cardiac complications. The range may include acute coronary syndrome, acute circulatory failure, severe arrhythmias, syncope and sudden cardiac death. The patient population...
Full record

US Clinical Trial NCT03231826 – NIH – Jul 24, 2017

Exploring Arrhythmias After Hospital Discharge in Post-Myocardial Infarction Patients - the MADDEC Project

Patients with acute myocardial infarction have exceptionally high mortality rates exceeding 10% during the first year post-MI. The incidence of sudden cardiac death after acute myocardial infarction is the same with ST-elevation and non-ST elevation...
Full record

US Clinical Trial NCT02099721 – NIH – Mar 26, 2014

Improve Sudden Cardiac Arrest Study

Devices allowed in the study include any Medtronic single, dual, or triple chamber defibrillator that has received appropriate license or regulatory approval and is commercially available by Medtronic in the geography in which the implant will take...
Full record
Register to view full records and advanced analytics.

US Clinical Trial NCT03837574 – NIH – Jan 27, 2019

French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator

Inclusion criteria: - patient with tetralogy of Fallot > 18 years - implantable cardioverter defibrillator (ICD) - primary or secondary prevention All french centers performing ICD implantation are annually contacted to include all patients w...
Full record

US Clinical Trial NCT03963271 – NIH – Apr 23, 2019

Noninvasive Electrocardiographic Imaging for Individuals at Risk for Apparently Idiopathic Ventricular Fibrillation.

ECGI combines electrical body-surface mapping with 256 electrodes placed on the thorax with a CT-scan obtaining the anatomy of the heart and torso, hereby able to reconstruct local electrograms, activation and recovery times. In recent research, ECG...
Full record